PURPOSE: Dysregulation of the extracellular matrix (ECM) plays an important role in the pathogenesis of age-related macular degeneration (AMD). Elastin is a fibrous protein constituent of the ECM, degradation of which may be detected by the presence of serum elastin-derived peptides (S-EDPs) in circulation. This study was undertaken to estimate levels of S-EDPs in patients with AMD compared with age-matched control subjects. METHODS: Fifty-six patients with AMD were classified into two groups: early age-related maculopathy (ARM) and neovascular AMD. The control group consisted of 15 age-matched subjects with no AMD. S-EDP levels in the serum of these subjects was estimated by competitive ELISA, using solubilized alpha-elastin from human aorta and polyclonal antibodies to this antigen. RESULTS: S-EDPs were significantly higher in patients with AMD than in control subjects. In addition, subjects with neovascular AMD had higher levels of S-EDPs than did those with early disease. CONCLUSIONS: The cause of this association between S-EDPs and AMD is unknown, but it suggests that systemic elastin degradation may increase the risk of conversion from early ARM to neovascular AMD. Further studies are needed to confirm whether the serum level of S-EDPs is a useful predictor of conversion from early ARM to neovascular AMD.
PURPOSE: Dysregulation of the extracellular matrix (ECM) plays an important role in the pathogenesis of age-related macular degeneration (AMD). Elastin is a fibrous protein constituent of the ECM, degradation of which may be detected by the presence of serum elastin-derived peptides (S-EDPs) in circulation. This study was undertaken to estimate levels of S-EDPs in patients with AMD compared with age-matched control subjects. METHODS: Fifty-six patients with AMD were classified into two groups: early age-related maculopathy (ARM) and neovascular AMD. The control group consisted of 15 age-matched subjects with no AMD. S-EDP levels in the serum of these subjects was estimated by competitive ELISA, using solubilized alpha-elastin from human aorta and polyclonal antibodies to this antigen. RESULTS:S-EDPs were significantly higher in patients with AMD than in control subjects. In addition, subjects with neovascular AMD had higher levels of S-EDPs than did those with early disease. CONCLUSIONS: The cause of this association between S-EDPs and AMD is unknown, but it suggests that systemic elastin degradation may increase the risk of conversion from early ARM to neovascular AMD. Further studies are needed to confirm whether the serum level of S-EDPs is a useful predictor of conversion from early ARM to neovascular AMD.
Authors: Narendra Dhingra; Susan Kelly; Mohammed A Majid; Claire B Bailey; Andrew D Dick Journal: Indian J Ophthalmol Date: 2010 Jan-Feb Impact factor: 1.848
Authors: Alex Jones; Sandeep Kumar; Ning Zhang; Zongzhong Tong; Jia-Hui Yang; Carl Watt; James Anderson; Heather Fillerup; Manabu McCloskey; Ling Luo; Zhenglin Yang; Balamurali Ambati; Robert Marc; Chio Oka; Kang Zhang; Yingbin Fu Journal: Proc Natl Acad Sci U S A Date: 2011-08-15 Impact factor: 11.205
Authors: Hyeong Gon Yu; Xiaoqing Liu; Szilard Kiss; Edward Connolly; Evangelos S Gragoudas; Norman A Michaud; Oleg V Bulgakov; Michael Adamian; Margaret M DeAngelis; Joan W Miller; Tiansen Li; Ivana K Kim Journal: Invest Ophthalmol Vis Sci Date: 2008-02-22 Impact factor: 4.799
Authors: Yoo Jin Hong; Jinhyun Kim; Bo Ram Oh; Yun Jong Lee; Eun Young Lee; Eun Bong Lee; Seung-Hyo Lee; Yeong Wook Song Journal: J Korean Med Sci Date: 2012-04-25 Impact factor: 2.153